Sylvia Kepa

Fibrinolysis in patients with a mild-to-moderate bleeding tendency of unknown cause

A. Kaider, H. Haslacher, C. Mannhalter, 2016, Annals of Hematology.

Epidemiology and Treatment of Patients with Haemophilia in Austria—Update from the Austrian Haemophilia Registry

P. Neumeister, C. Male, I. Pabinger, 2018, Hämostaseologie.

High proportion of patients with bleeding of unknown cause in persons with a mild‐to‐moderate bleeding tendency: Results from the Vienna Bleeding Biobank (VIBB)

S. Eichinger, P. Kyrle, H. Haslacher, 2018, Haemophilia : the official journal of the World Federation of Hemophilia.

FVIII-binding IgG modulates FVIII half-life in patients with severe and moderate hemophilia A without inhibitors.

M. Schemper, C. Mannhalter, B. Reipert, 2016, Blood.

Parameters influencing FVIII pharmacokinetics in patients with severe and moderate haemophilia A

M. Schemper, P. Neumeister, C. Mannhalter, 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

Factor VIII pharmacokinetics associates with genetic modifiers of VWF and FVIII clearance in an adult hemophilia A population

W. Hopman, D. Lillicrap, I. Pabinger, 2020, Journal of thrombosis and haemostasis : JTH.

Influence of Imprinting of an X Chromosome and of the MethyleneTetrahydrofolate Reductase (MTHFR) 677C>T Polymorphism on FVIII Activity

R. Sunder-Plassmann, C. Mannhalter, C. Male, 2015 .